Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bardoxolone methyl in T2D and CKD
NCT01053936Phase 2Completed
- Sponsor
- Biogen
- Start
- Jan 2010
- Primary completion
- Dec 2010
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bardoxolone methyl in chronic kidney disease (CKD), sponsored by Biogen. Started Jan 2010; status: completed.
02
Drugs
bardoxolone methyl
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01053936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053936.